Subclinical Cardiovascular Disease Markers and Vitamin D Deficiency in Non-dialysis Chronic Kidney Disease Patients

Overview

Journal Arch Med Sci

Specialty General Medicine

Date 2016 Oct 4

PMID 27695492

Citations 13

Authors

Cristina Capusa

Gabriel Stefan

Simona Stancu

Andrea Ilyes

Nicoleta Dorobantu

Gabriel Mircescu

Affiliations

Soon will be listed here.

Abstract

Introduction: Since 25-hydroxyvitamin D (25(OH)D) deficiency has been linked to an increased risk for cardiovascular disease (CVD) in the hemodialysis population, we aimed to determine the relationship between serum 25(OH)D level and markers of subclinical CVD in non-dialysis chronic kidney disease (CKD) patients.

Material And Methods: This cross-sectional, single-center study prospectively enrolled 87 clinically stable CKD patients (median age: 61 (57-66) years, 51% male, median estimated glomerular filtration rate (eGFR): 32 (27-37) ml/min). Five markers of subclinical CVD were assessed: intima-media thickness, abdominal aortic calcifications (AAC) using the Kauppila score, cardio-ankle vascular index, ankle-brachial index (ABI) and interventricular septum thickness.

Results: Vascular (37%), glomerular (23%) and interstitial (18%) nephropathies were the main causes of CKD. 25(OH)D had a median value of 14 (12.5-17.1) ng/ml, and its levels decreased with eGFR ( = 0.19; = 0.04). Patients with 25(OH)D deficiency (54%) were older, had a higher serum alkaline phosphatase level, lower ABI and higher AAC score. There were no differences between the two groups regarding other traditional or non-traditional risk factors for atherosclerosis. The association between subclinical CVD markers and 25(OH)D was further evaluated in multivariable binomial logistic regression models adjusted for CV risk factors. Lower 25(OH)D level was retained as an independent predictor only for pathological ABI.

Conclusions: This is the first study to evaluate the relationship between a large set of subclinical CVD markers and 25(OH)D deficiency in non-dialysis CKD patients. We found that hypovitaminosis D is associated with subclinical peripheral arterial disease, independently of other cardiovascular risk factors.

Citing Articles

VITAMIN D DEFICIENCY, BONE TURNOVER MARKERS AND ARTERIAL CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS.

Chiriac C, Ciurea O, Lipan M, Capusa C, Mircescu G Acta Endocrinol (Buchar). 2024; 20(1):12-20.

PMID: 39372299 PMC: 11449234. DOI: 10.4183/aeb.2024.12.

Evaluation of MicroRNA 145 and MicroRNA 155 as Markers of Cardiovascular Risk in Chronic Kidney Disease.

Kumar A, Priyadarshini G, Parameswaran S, Ramesh A, Rajappa M Cureus. 2024; 16(8):e66494.

PMID: 39246913 PMC: 11380758. DOI: 10.7759/cureus.66494.

Association of serum 25-hydroxyvitamin D3, fibroblast growth factor-23, and C1q/tumor necrosis factor-related protein-3 with coronary artery calcification in nondialysis chronic kidney disease patients.

Zhu Y, Hu Z, Liu Y, Qin C, Chen X, Shi Y Ren Fail. 2023; 45(1):2220412.

PMID: 37293793 PMC: 10259302. DOI: 10.1080/0886022X.2023.2220412.

Insulin Resistance and Vitamin D Deficiency: A Link Beyond the Appearances.

Trimarco V, Manzi M, Mancusi C, Strisciuglio T, Fucile I, Fiordelisi A Front Cardiovasc Med. 2022; 9:859793.

PMID: 35369303 PMC: 8968037. DOI: 10.3389/fcvm.2022.859793.

Effect of Vitamin D Supplementation on the Regulation of Blood Pressure in Iranian Patients with Essential Hypertension: A Clinical Trial.

Panahi Y, Namazi S, Rostami-Yalmeh J, Sahebi E, Khalili N, Jamialahmadi T Adv Exp Med Biol. 2022; 1328:501-511.

PMID: 34981501 DOI: 10.1007/978-3-030-73234-9_35.

References

Foley R, Parfrey P, Sarnak M . Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 2001; 9(12 Suppl):S16-23. View

Sigrist M, Taal M, Bungay P, McIntyre C . Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol. 2007; 2(6):1241-8. DOI: 10.2215/CJN.02190507. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T . Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb. 2011; 18(11):924-38. DOI: 10.5551/jat.7716. View

Lomashvili K, Garg P, Narisawa S, Millan J, ONeill W . Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int. 2008; 73(9):1024-30. PMC: 3010853. DOI: 10.1038/ki.2008.26. View

Nikodimopoulou M, Liakos S . Secondary hyperparathyroidism and target organs in chronic kidney disease. Hippokratia. 2011; 15(Suppl 1):33-8. PMC: 3139677. View

Mehrotra R, Kermah D, Salusky I, Wolf M, Thadhani R, Chiu Y . Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009; 76(9):977-83. PMC: 3791220. DOI: 10.1038/ki.2009.288. View

Pilz S, Marz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai H . Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008; 93(10):3927-35. DOI: 10.1210/jc.2008-0784. View

Guillot X, Semerano L, Saidenberg-Kermanach N, Falgarone G, Boissier M . Vitamin D and inflammation. Joint Bone Spine. 2010; 77(6):552-7. DOI: 10.1016/j.jbspin.2010.09.018. View

10.

Melamed M, Muntner P, Michos E, Uribarri J, Weber C, Sharma J . Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol. 2008; 28(6):1179-85. PMC: 2705139. DOI: 10.1161/ATVBAHA.108.165886. View

11.

Melamed M, Astor B, Michos E, Hostetter T, Powe N, Muntner P . 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol. 2009; 20(12):2631-9. PMC: 2794237. DOI: 10.1681/ASN.2009030283. View

12.

Pilz S, Iodice S, Zittermann A, Grant W, Gandini S . Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis. 2011; 58(3):374-82. DOI: 10.1053/j.ajkd.2011.03.020. View

13.

Drechsler C, Verduijn M, Pilz S, Dekker F, Krediet R, Ritz E . Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant. 2010; 26(3):1024-32. DOI: 10.1093/ndt/gfq606. View

14.

Preston E, Ellis M, Kulinskaya E, Davies A, Brown E . Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD. Am J Kidney Dis. 2005; 46(5):856-62. DOI: 10.1053/j.ajkd.2005.07.048. View

15.

Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P . Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of.... J Am Soc Echocardiogr. 2005; 18(12):1440-63. DOI: 10.1016/j.echo.2005.10.005. View

16.

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

17.

Michaud J, Naud J, Ouimet D, Demers C, Petit J, Leblond F . Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol. 2010; 21(9):1488-97. PMC: 3013518. DOI: 10.1681/ASN.2009080815. View

18.

Ganesh S, Stack A, Levin N, Hulbert-Shearon T, Port F . Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001; 12(10):2131-2138. DOI: 10.1681/ASN.V12102131. View

19.

Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P . Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2008; 75(1):88-95. DOI: 10.1038/ki.2008.501. View

20.

Chitalia N, Recio-Mayoral A, Kaski J, Banerjee D . Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis. 2011; 220(1):265-8. DOI: 10.1016/j.atherosclerosis.2011.10.023. View